Literature DB >> 9423926

Action of delta-9-tetrahydrocannabinol on GABA(A) receptor-mediated responses in a grease-gap recording preparation of the rat hippocampal slice.

M A Coull1, A T Johnston, R G Pertwee, S N Davies.   

Abstract

We have investigated the effects of delta-9-tetrahydrocannabinol (delta-9-THC) on gamma-aminobutyric acid (GABA) receptor-mediated responses in a grease-gap recording preparation of the rat hippocampus. GABA, and the selective GABA(A) receptor agonist muscimol, evoked depolarizing responses with EC50 values of 8.5 mM and 17.0 microM, respectively. Responses to both of these agonists were selectively reduced by the non-competitive GABA(A) antagonist picrotoxin (5 microM), but were unaffected by the GABA(B) antagonist 2-hydroxysaclofen (500 microM). Responses evoked by the selective GABA(B) receptor agonist baclofen were not sufficiently large to analyse. The GABA uptake inhibitor, nipecotic acid (500 microM), potentiated responses to GABA, but not to muscimol. Similarly, 10-1000 nM delta-9-THC had no significant effect on the response to muscimol, whereas 1000 nM delta-9-THC significantly increased the response to GABA. Since GABA is the substrate of an avid uptake system, but muscimol is not, the results are consistent with the suggestion that delta-9-THC inhibits the uptake of GABA in the hippocampus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9423926     DOI: 10.1016/s0028-3908(97)00110-x

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

1.  Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons.

Authors:  I Katona; B Sperlágh; A Sík; A Käfalvi; E S Vizi; K Mackie; T F Freund
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

2.  Separate and combined effects of the GABA reuptake inhibitor tiagabine and Δ9-THC in humans discriminating Δ9-THC.

Authors:  Joshua A Lile; Thomas H Kelly; Lon R Hays
Journal:  Drug Alcohol Depend       Date:  2011-10-04       Impact factor: 4.492

Review 3.  Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention.

Authors:  Mackenzie E Hofmann; Charles J Frazier
Journal:  Exp Neurol       Date:  2011-12-09       Impact factor: 5.330

4.  Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus.

Authors:  Nora Laaris; Cameron H Good; Carl R Lupica
Journal:  Neuropharmacology       Date:  2010-04-22       Impact factor: 5.250

5.  Delta(9)-THC-induced cognitive deficits in mice are reversed by the GABA(A) antagonist bicuculline.

Authors:  S A Varvel; E Anum; F Niyuhire; L E Wise; A H Lichtman
Journal:  Psychopharmacology (Berl)       Date:  2004-08-20       Impact factor: 4.530

6.  Olfactory Hallucinations without Clinical Motor Activity: A Comparison of Unirhinal with Birhinal Phantosmia.

Authors:  Robert I Henkin; Samuel J Potolicchio; Lucien M Levy
Journal:  Brain Sci       Date:  2013-11-15

Review 7.  Synaptic targets of Δ9-tetrahydrocannabinol in the central nervous system.

Authors:  Alexander F Hoffman; Carl R Lupica
Journal:  Cold Spring Harb Perspect Med       Date:  2013-08-01       Impact factor: 6.915

8.  Influence of tiagabine maintenance on cannabis effects and related behaviors in daily cannabis users.

Authors:  Michael J Wesley; Philip M Westgate; William W Stoops; Thomas H Kelly; Lon R Hays; Joshua A Lile
Journal:  Exp Clin Psychopharmacol       Date:  2018-06       Impact factor: 3.157

9.  Cannabinoids disrupt memory encoding by functionally isolating hippocampal CA1 from CA3.

Authors:  Roman A Sandler; Dustin Fetterhoff; Robert E Hampson; Sam A Deadwyler; Vasilis Z Marmarelis
Journal:  PLoS Comput Biol       Date:  2017-07-07       Impact factor: 4.475

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.